|
Company
Roster
|
Total
Insiders : |
42 |
|
|
Total
Direct Shares :
|
327,493,834 |
|
Total
Indirect Shares :
|
186,981,182 |
|
%
Held by Insiders:
|
2167.11% |
|
|
|
Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Gordon Edwin H. |
|
|
0 |
|
0 |
Matkovits Theresa |
|
|
0 |
|
0 |
Turanin John J |
Officer |
2003-05-10 |
9,008 |
|
0 |
Rigby Jonathan |
Officer |
2006-03-07 |
8,000 |
|
0 |
Grimes D Jeffery |
VP Legal Affairs, Secretary |
2010-01-08 |
344,662 |
|
0 |
Def Associates Lp |
10% Owner |
2010-12-31 |
2,098,800 |
|
0 |
Siebert John M |
Director |
2013-05-22 |
501,697 |
|
0 |
Grifols Sa |
Director, 10% Owner |
2013-08-27 |
209,774,558 |
|
0 |
Nea Partners 10 L P |
10% Owner |
2003-12-11 |
0 |
2003-12-11 |
0 |
Barrett M James |
10% Owner |
2003-12-11 |
2,905 |
2003-12-11 |
0 |
Sandell Scott D |
10% Owner |
2003-12-11 |
0 |
2003-12-17 |
0 |
Trainor III Eugene A |
10% Owner |
2004-01-07 |
0 |
2004-01-07 |
0 |
Morris Peter |
10% Owner |
2003-12-11 |
0 |
2004-02-20 |
0 |
Nehra John M |
Director |
2003-12-11 |
292 |
2004-02-20 |
0 |
Barris Peter J |
10% Owner |
2003-12-11 |
0 |
2004-02-20 |
0 |
Dorman Nancy L |
10% Owner |
2003-12-11 |
0 |
2004-02-20 |
0 |
Mcconnell Thomas C |
10% Owner |
2003-12-11 |
0 |
2004-02-20 |
0 |
Newhall Charles W III |
10% Owner |
2003-12-11 |
51 |
2004-02-20 |
0 |
Alsop Stewart Ii |
10% Owner |
2003-12-11 |
0 |
2004-02-20 |
0 |
Kase Ronald H |
Former 10% Holder |
2003-12-15 |
0 |
2004-02-20 |
0 |
Perry Mark W |
10% Owner |
2003-12-11 |
0 |
2004-03-04 |
0 |
Ra Capital Biotech Fund Lp |
10% Owner |
|
0 |
2007-01-24 |
6,355,000 |
Tang Capital Management Llc |
10% Owner |
|
0 |
2007-01-25 |
5,780,000 |
Otulana Babtunde A |
VP of Clincal Affairs |
2007-01-25 |
8,020 |
2007-01-25 |
0 |
Gonda Igor |
Chief Executive Officer, Director |
2017-06-01 |
146,766 |
2007-01-25 |
0 |
Kolchinsky Peter |
10% Owner |
2007-03-01 |
0 |
2008-01-15 |
7,681,410 |
Barker Frank H |
Director |
2013-05-22 |
941,645 |
2008-04-02 |
0 |
Lynch Timothy P |
Director |
2008-07-01 |
0 |
2008-07-01 |
240,000 |
Ra Capital Biotech Fund Ii, L.p. |
10% Owner |
2007-03-01 |
89,010 |
2008-10-06 |
6,681,410 |
Tang Capital Partners Lp |
10% Owner |
2008-10-21 |
70,000 |
2008-10-21 |
5,877,000 |
Aldrich Richard |
10% Owner |
2008-10-29 |
0 |
2008-10-29 |
1,081,410 |
Pecota Nancy E |
VP and CFO |
2017-06-01 |
110,827 |
2009-01-21 |
0 |
Thompson Virgil |
Director |
2013-12-13 |
1,006,722 |
2009-05-15 |
0 |
Howson Tamar D |
Director |
2012-05-25 |
132,331 |
2010-11-03 |
0 |
Novo Nordisk A S |
10% Owner |
2010-09-16 |
27,573,672 |
2010-11-05 |
26,204,122 |
Def Associates N.v. |
See footnotes below, 10% Owner |
2012-01-01 |
0 |
2011-07-07 |
71,357,909 |
Lewis Joseph |
10% Owner |
2013-05-20 |
57,517,914 |
2013-05-20 |
51,512,735 |
Short Helen E |
Director |
2013-05-22 |
80,000 |
2013-05-22 |
0 |
Def Associates Ltd. |
10% Owner |
2012-01-01 |
7,473,328 |
2013-08-27 |
0 |
Froehlich Juergen Kurt |
Chief Medical Officer |
2018-10-26 |
151,485 |
2014-10-01 |
0 |
21 April Fund Lp |
10% Owner |
2010-09-21 |
0 |
2018-02-01 |
4,210,186 |
Arnhold & S. Bleichroeder Advisers, Llc |
10% Owner |
2009-12-09 |
19,452,141 |
2019-09-01 |
0 |
|